Concepedia

Tatyana Korontsvit

TK

26

Publications

2.2K

Citations

19

H-Index

1996

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Eureka Therapeutics (United States)

Weill Cornell Medicine

Kettering University

Tatyana Korontsvit is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, immunology, and cell biology.

ORCID

Top concepts

Publications per year

1996–2023

26

Publications

26

Specific human cellular immunity to bcr-abl oncogene-derived peptides

Monica Bocchia, Tatyana Korontsvit, Qin Xu et al. · Blood · 1996 · 289 citations

Vaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responses

Javier Pinilla‐Ibarz, Kathleen N. S. Cathcart, Tatyana Korontsvit et al. · Blood · 2000 · 246 citations

A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia

Kathleen N. S. Cathcart, Javier Pinilla‐Ibarz, Tatyana Korontsvit et al. · Blood · 2003 · 204 citations · Full text

Single-Walled Carbon Nanotubes Deliver Peptide Antigen into Dendritic Cells and Enhance IgG Responses to Tumor-Associated Antigens

Carlos H. Villa, Tao Dao, Ian M. Ahearn et al. · ACS Nano · 2011 · 203 citations · Full text

Targeting the Intracellular WT1 Oncogene Product with a Therapeutic Human Antibody

Tao Dao, Su Yan, Nicholas Veomett et al. · Science Translational Medicine · 2013 · 178 citations

Rows per page

1–5 of 26